Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
5.90
-0.13 (-2.16%)
At close: Jun 26, 2026, 4:00 PM EDT
6.01
+0.11 (1.86%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Savara Employees
Savara had 70 employees as of December 31, 2025. The number of employees increased by 11 or 18.64% compared to the previous year.
Employees
70
Change (1Y)
11
Growth (1Y)
18.64%
Revenue / Employee
n/a
Profits / Employee
-$1,849,743
Market Cap
1.50B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Novavax | 749 |
| Immunocore Holdings | 524 |
| Maravai LifeSciences Holdings | 416 |
| Capricor Therapeutics | 231 |
| Maze Therapeutics | 141 |
| MapLight Therapeutics | 133 |
| MoonLake Immunotherapeutics | 130 |
SVRA News
- 15 days ago - Savara Announces New Employment Inducement Grant - Business Wire
- 19 days ago - Savara says CFO Dave Lowrance stepping down for health reasons - TheFly
- 19 days ago - Savara Announces Chief Financial and Administrative Officer Transition - Business Wire
- 23 days ago - Savara Transcript: AGM 2026 - Transcripts
- 25 days ago - Savara Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference - Business Wire
- 5 weeks ago - Savara presents poster at ATS 2026 International Conference on IMPALA-2 - TheFly
- 5 weeks ago - Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2026 - Business Wire